- GlobeNewswire•7 days agoKamada Announces Collaboration with Massachusetts General Hospital for Proof of Concept Study Evaluating Benefit of Liquid Alpha-1 Antitrypsin on Liver Preservation Prior to Transplantation
NESS ZIONA, Israel, Feb. 21, 2017-- Kamada Ltd., a plasma-derived protein therapeutics company focused on orphan indications, announced today a collaboration with Massachusetts General Hospital to conduct ...
- GlobeNewswire•20 days agoKamada Announces Appointment of Biopharmaceutical Industry Veteran, Gwen Melincoff, to its Board of Directors
NESS ZIONA, Israel, Feb. 08, 2017-- Kamada Ltd., a plasma-derived protein therapeutics company focused on orphan indications, announced today the appointment of Gwen A. Melincoff to the Company’ s Board ...
- Associated Press•22 days ago
The Ness Ziona, Israel-based company said it had a loss of 5 cents per share. The biopharmaceutical posted revenue of $24.3 million in the period. For the year, the company reported that its loss narrowed ...
KMDA.TA : Summary for KAMADA ORD ILS1.00 - Yahoo Finance
Kamada Ltd. (KMDA.TA)
Tel Aviv - Tel Aviv Delayed Price. Currency in ILS
Add to watchlist
|Bid||2,545.00 x 346500|
|Ask||2,547.00 x 57900|
|Day's Range||2,550.00 - 2,630.00|
|52 Week Range||14.01 - 2,630.00|
|PE Ratio (TTM)||-13,800.00|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|